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Results: 4719 patients (88.6%) were analysed (2781 with 
knee, 1553 with hip, and 385 with hip and knee osteoarthritis). 
Mean scores of the WOMAC (range 0-100) were 48.74-17.9, 
47.24-17.4, and 52.24-17.5 for the 17, nine, and eight item- 
versions respectively. We observed no difference in mean scores 
between knee and hip osteoarthritis. For the three versions of the 
questionnaire, the Cronbach coefficient values were high (0.96, 
0.91, and 0.92 respectively). For each osteoarthritis location, fac- 
tor analysis of the 17-item version extracted two similar factors 
which could not be clinically characterised, explaining 67% of the 
total variance for hip OA and 63% of the total variance for knee 
OA. Factor analysis of the nine-item version extracted one fac- 
tor explaining 60% of the total variance for knee and two fac- 
tors (which could not be clinically characterised) explaining 72% 
of the total variance for hip osteoarthritis. The eight-item version 
was one-dimensional for knee and hip OA, explaining 61.0% and 
61.5% of total variance. The mean scores of the three WOMAC 
versions were highly correlated but were weakly correlated with 
pain scores (r values between 0.42 and 0.53). 
Conclusions: Mean scores of the 3 versions of the WOMAC 
questionnaire, section C are highly correlated, but the eight-item 
version has the advantage of being one-dimensional for both lo- 
cations of the disease. Disability assessed by the WOMAC ques- 
tionnaire is similar for both hip and knee osteoarthritis. 
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Introduction: There are many treatment pathways for os- 
teoarthritis of the knee; however the outcome may not match the 
patient's expectations. The purpose of this study was to identify 
the expectations of treatment in patients with osteoarthritis of the 
knee. 
Methods: A 20 item validated knee surgery expectation survey 
was completed by 130 individuals, 50 years or older, who were 
diagnosed with knee osteoarthritis. There were 54 women and 
76 men with a mean age of 63 years(range 50 - 91). 
Results: Avoid future knee degeneration was the most com- 
mon expectation rated very important(85%), followed by improve 
ability to maintain health(79%), have confidence in knee(69%), 
and improve ability to walk(69%). The least common expecta- 
tion was for the knee to be back to way it was before the prob- 
lem started, followed by improve ability to run. Gender was as- 
sociated (p<0.05) with the following expectations: avoid future 
degeneration(more important o females), improve ability to do 
stairs(more important o females), improve ability to kneel(more 
important o males), and stop knee from giving way when stop- 
ping quickly(more important to males). Age was associated 
(p<0.05) with pain relief(more important to younger) and improve 
ability to participate in sport(more important to younger). Improve 
ability to maintain health was more important to older individuals, 
as was avoid future degeneration of the knee. 
Conclusions: Patient expectations are influenced by age and 
gender. These differences are important in clinical decision mak- 
ing. Further understanding of patients' expectations of treatment 
may improve treatment outcome and patient satisfaction. 
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Aim of study: After observing that three patients with both knee 
osteoarthritis and psoriasis treated with chondroitin sulfate ex- 
perienced a marked improvement of skin lesions, we decided to 
study more cases due to the encouraging preliminary results. 
Here, we describe the clinical and histopathological results of 
eleven patients with both osteoarthritis and psoriasis treated with 
oral chondroitin sulfate. 
Methods: Eleven adult patients with knee osteoarthritis and long- 
standing moderate to severe psoriasis resistant to conventional 
therapy received 800 mg/day of chondroitin sulfate (Bioiberica 
S.A., Barcelona, Spain) for two months. Skin biopsies were ob- 
tained before and after treatment. 
Results: Clinically, all patients but one presented a dramatic im- 
provement of the condition of the skin with a reduction of swelling, 
redness, flaking, and itching, increase in the hydration and soft- 
ening of the skin, and amelioration of scaling. One patient expe- 
rienced clearance of psoriasis. Histopathologically, there was a 
statistically significant decrease in epidermal thickness (-29%), 
a decrease in the thickness between the stratum basale and 
the stratum granulosum (-31%), a significant improvement of the 
degree of psoriasis activity (-49%), and a decrease in the ker- 
atinocyte proliferation index (-27%). The substitution of paraker- 
atotic keratinization by orthokeratotic keratinization was also ob- 
served. 
Conclusions: The administration of chondroitin sulfate resulted 
in a marked improvement of the psoriatic lesions. Therefore, the 
confirmation of these findings in controlled prospective studies 
could represent an important advance in the therapeutic arma- 
mentarium for patients with psoriasis given the excellent safety 
profile of chondroitin sulfate. 
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Aims: To compare the effectiveness of Ostenil Mini (a Sodium 
Hyaluronate designed specifically for small joint Osteoarthritis) to 
a standard injection of Depomedrone for base of thumb arthritis. 
Methods: After obtaining ethical approval 20 patients were re- 
cruited from the Rheumatology and Hand clinics at a busy dis- 
trict general hospital and gave consent to be included in the trial. 
Patients received either an injection of Depomedrone or an in- 
jection of Ostenil mini. Due to bilateral disease there were 23 
injections, 10 of Depomedrone and 13 of Ostenil mini. Most pa- 
tients were female; 2 males, and only 2 were left-handed, both 
of these had isolated left sided disease. Each patient was as- 
sessed prior to the injection using the Patient Rated Wrist Evalua- 
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tion (PREW) questionnaire and the Short Form 36 questionnaires 
as well as physical measurements of power grip and pinch grip 
to both hands were recorded. Subsequent assessment with the 
PREW at 6 weeks and all the questionnaires and measurements 
repeated at 3 months following the injection. 
Results: Asked to rate the overall effectiveness of the injection 
(useless, poor, fair, good or excellent): 8 out of 13 of the Ostenil 
group gave ratings of good or excellent (2 poor and 3 fair). Of 
those receiving the Depomedrone only 4 out of 10 rated the in- 
jection as good (none rated excellent, 3 fair and 3 useless). The 
clinician performing the injections noted the patients' comments 
at the time of injection and not only were the injections them- 
selves less painful but the post-injection discomfort was less in 
the Ostenil group. 
The majority of both groups scored worse with the PREW at post- 
injection assessments despite rating their outcomes as mainly 
good in the Ostenil group. The SF-36 proved largely inconclusive, 
most patients were affected by polyarthropathy and this seemed 
to have a significant influence over patients' answers. 
The power and pinch grip measurements were complex to inter- 
pret; between a third and a half of both groups had less strength 3 
months following the injection, two of them who both had Ostenil 
bilaterally scored better on one side and worse on the other. All 
the results are analysed and presented in detail. 
Conclusions: Ostenil mini scored higher in patient general sat- 
isfaction and was less painful both at the time of injection and in 
the post-injection period. Questionnaires and physical measure- 
ments were largely inconclusive. Neither group had any serious 
complications. 
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Resorption and bone formation are the processes strictly linked 
to each other. The inhibition of osteoclast activity causes simul- 
taneous inhibition of recruitment and maturation of osteoblasts. 
Osteoarthritic subchondral osteoblasts due to RANK activation 
by RANKL would be responsible for articular cartilage degenera- 
tion in certain conditions as a result of proinflammatory c tokines 
overproduction. 
A phenomenon of simultaneous increase in bone resorption and 
intensification of clinical symptoms of degenerative disease in 
women soon after their ovaries ceased to function is understand- 
ably interesting. Thus, the role of estrogens in both processes 
should be checked thoroughly. They are able to act through re- 
ceptors, which appear in osteoblasts, osteoclasts, and chondro- 
cytes. It is similar to the cases of specific modulators of estro- 
gen receptor (SERM), which affect the same receptors in the 
bone and cartilage. At the same time, we revealed the inhibition 
of cartilage degradation marker excretion (CTX-II/Cr) influenced 
by RLX 12-month-treatment in women with knee osteoarthritis 
(OAK). The influence of estrogen replacement herapy in inhibi- 
tion of OA progress in post-menopausal women has been docu- 
mented well but a similar effect of SERM drugs, specifically the 
best known so far RLX, awaits investigation. 
The aim of the study was the evaluation of clinical algo-functional 
parameters of WOMAC and Lequesne indexes before and after 
12 months of Raloxyfene (RLX) therapy. 
The study was carried out in the group of 65 women, aged 52-79 
years, mean 65.4 years, with diagnosed (according to ACR crite- 
ria and rated on a 3-point of Kellgren and Lawrence score) knee 
osteoarthritis, with low bone mass (BMD of Hip and/or L2-L4 ver- 
tebrae T-score between -1.0 and -2.5), without contraindications 
to be treated with RLX. Patients were randomly assigned to the 
control (C) or to the examined group (E) being treated with 60mg 
of RLX. All participants took Calcium up to 1200mg and 8001.U. 
of Vitamin D3 and Tramadol 1-2x50mg/24hr in case of pain. Clin- 
ical evaluation of knee symptoms was based on WOMAC and 
Lequesne indexes. 
The results pointed to a significant improvement of WOMAC index 
(p=0.002). Lequesne test's results were on the border of signifi- 
cance (p=0.05) and testing level of probability for CTX-II/Cr and 
WOMAC correlation was p=0.058. 
Conclusion: Raloxifene administered to women with OAK for 12 
months caused the decrease in cartilage degradation with simul- 
taneous clinical improvement, measured with WOMAC index and, 
to a smaller extent, with Lequesne one. Thus, it proves Raloxifene 
to have antiosteoarthritic effect. 
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Aim: Using finite element (FE) computer models of intact and 
fractured ankles from patients, we aim to characterize degenera- 
tion propensity due to aberrant contact stress exposure following 
intra-articular f acture of the ankle. This is approached by patient- 
specific analysis of cumulative cartilage mechano-stimulus at- 
tributable to habitual functional activity. 
Methods: CT scans of human ankles (6 surgically reduced tib- 
ial plafond fractures and 7 intact contralaterals) were segmented 
to delineate bony margins. Each bone surface was projected out- 
ward to create a second surface, with the intervening volume then 
meshed with continuum hexahedral cartilage elements. The tibia 
was positioned relative to the talus into a weight-bearing apposi- 
tion. 
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Articular members were first engaged under light preload, then 
plantar-/dorsi-flexion kinematics and resultant Ioadings were in- 
put for serial FE solutions at 13 instants of the stance phase of 
level walking gait. Cartilage stress histories were post-processed 
to recover distributions of cumulative stress-time mechano- 
stimulus, a metric of degeneration propensity. 
Results: Computed contact stress distributions for intact ankle 
joints were continuous and relatively uniform over the contact 
patch, which was relatively consistently located on the tibial ar- 
ticular surface. The average peak computed contact stress was 
11(4-1) MPa for intact ankles (consistent with previous experi- 
mental cadaveric recordings), and 14(4-2) MPa in fractured an- 
kles. Consistency in computed contact stress exposures for intact 
